Pharmaceutical Company increases its stake in Enaya to 63% for 45 million riyals
The Saudi Pharmaceutical Industries and Medical Supplies Company (Spimaco Pharmaceuticals) has concluded a binding agreement to acquire an additional 12% of the ownership of the Arab Medical Products Manufacturing Company (Enaya), a company in which Spimaco Pharmaceuticals currently owns a 51% stake.
According to a statement on "Saudi Arabia trading"share goes up "Pharmacokinetics" After the acquisition process is completed, it reaches 63%, as the acquisition process will take place through purchasing a share from a company "Alexandra Health"
The value of the deal is 45 million riyals ($12 million), financed from the company’s own resources, and its terms include amending the company’s articles of incorporation, issuing a new commercial registry by the Ministry of Commerce, and the General Authority for Competition’s non-objection to the acquisition.
About the targeted asset
Enaya is one of the leading companies in manufacturing a wide range of single-use medical products, including surgical gowns, personal protective equipment, custom surgical kits, wound care accessories, and surgical products. Sterilization.
Enaya’s revenues for the year 2025 amounted to about 237 million riyals, while the net profit for the same year amounted to 45.36 million riyals.
It is expected that the financial impact of this acquisition will begin to be reflected in the financial statements as of the second half of 2026.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
